Publicaciones en las que colabora con Zoraida Verde Rello (8)

2014

  1. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6 ?

    Pharmacopsychiatry, Vol. 47, Núm. 1, pp. 33-36

2011

  1. 'Smoking Genes': A genetic association study

    PLoS ONE, Vol. 6, Núm. 10

2010

  1. A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants

    PLoS ONE, Vol. 5, Núm. 6

  2. ACE and ACTN3 genes and muscle phenotypes in nonagenarians

    International Journal of Sports Medicine, Vol. 31, Núm. 4, pp. 221-224

2009

  1. Genotype distributions in top-level soccer players: A role for ace ?

    International Journal of Sports Medicine, Vol. 30, Núm. 5, pp. 387-392

  2. Is there an optimum endurance polygenic profile?

    Journal of Physiology, Vol. 587, Núm. 7, pp. 1527-1534

  3. Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORCI c.-l 639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 591-593

  4. Unique among unique. Is it genetically determined?

    British Journal of Sports Medicine, Vol. 43, Núm. 4, pp. 307-309